NasdaqGS - Nasdaq Real Time Price USD

Bolt Biotherapeutics, Inc. (BOLT)

Compare
0.6264 -0.0116 (-1.82%)
At close: October 18 at 4:00 PM EDT
0.6165 -0.01 (-1.58%)
After hours: October 18 at 4:06 PM EDT

Research Analysis

Earnings Per Share

Consensus EPS
?

Revenue vs. Earnings

Revenue 1.27M
Earnings -21.2M
?

Analyst Recommendations

  • Strong Buy
  • Buy
  • Hold
  • Underperform
  • Sell
?

Analyst Price Targets

1.50
1.75 Average
0.6264 Current
2.00 High

Earnings Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 4444
Avg. Estimate -0.35-0.32-1.51-1.28
Low Estimate -0.46-0.36-1.66-2.15
High Estimate -0.24-0.26-1.34-0.91
Year Ago EPS -0.43-0.47-1.83-1.51

Revenue Estimate

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
No. of Analysts 4444
Avg. Estimate 1.26M1.19M8.98M3.64M
Low Estimate 500k400k7.4M--
High Estimate 2M2M10.5M9.99M
Year Ago Sales 2.53M2.09M7.88M8.98M
Sales Growth (year/est) -50.20%-43.00%14.00%-59.50%

Earnings History

CURRENCY IN USD 9/30/2023 12/31/2023 3/31/2024 6/30/2024
EPS Est. -0.5-0.48-0.51-0.48
EPS Actual -0.43-0.47-0.28-0.56
Difference 0.070.010.23-0.08
Surprise % 14.00%2.10%45.10%-16.70%

EPS Trend

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Current Estimate -0.35-0.32-1.51-1.28
7 Days Ago -0.35-0.32-1.51-1.28
30 Days Ago -0.35-0.32-1.51-1.28
60 Days Ago -0.35-0.32-1.51-1.28
90 Days Ago -0.3-0.27-1.34-1.07

EPS Revisions

CURRENCY IN USD Current Qtr. (Sep 2024)Next Qtr. (Dec 2024)Current Year (2024)Next Year (2025)
Up Last 7 Days --------
Up Last 30 Days --------
Down Last 7 Days --------
Down Last 30 Days --------

Growth Estimates

CURRENCY IN USD BOLTIndustrySectorS&P 500
Current Qtr. 18.60%----3.70%
Next Qtr. 31.90%----7.90%
Current Year 17.50%----2.50%
Next Year 15.20%----13.10%
Next 5 Years (per annum) ------11.88%
Past 5 Years (per annum) --------

Upgrades & Downgrades

Reiterates HC Wainwright & Co.: Neutral 8/15/2024
Downgrade Leerink Partners: Outperform to Market Perform 5/15/2024
Downgrade Jones Trading: Buy to Hold 5/15/2024
Downgrade HC Wainwright & Co.: Buy to Neutral 5/15/2024
Downgrade Guggenheim: Buy to Neutral 5/15/2024
Downgrade Stifel: Buy to Hold 5/15/2024

Related Tickers